The FDA and CDC have expanded eligibility for bivalent COVID-19 boosters to include children as young as five years old. NPR's Rob Stein reported on the expansion, while noting that experts like Dr. Paul Offit have pointed out a lack of data proving the bivalent shots are superior to original versions. Public health officials expressed concern over low uptake, as only 15% of eligible adults have received the new booster since Labor Day.



